These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25263444)

  • 1. Protein tyrosine phosphatase PTPN3 inhibits lung cancer cell proliferation and migration by promoting EGFR endocytic degradation.
    Li MY; Lai PL; Chou YT; Chi AP; Mi YZ; Khoo KH; Chang GD; Wu CW; Meng TC; Chen GC
    Oncogene; 2015 Jul; 34(29):3791-803. PubMed ID: 25263444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate specificity and plasticity of FERM-containing protein tyrosine phosphatases.
    Chen KE; Li MY; Chou CC; Ho MR; Chen GC; Meng TC; Wang AH
    Structure; 2015 Apr; 23(4):653-64. PubMed ID: 25728925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential parsing of EGFR endocytic flux among parallel internalization pathways in lung cancer cells with EGFR-activating mutations.
    Walsh AM; Lazzara MJ
    Integr Biol (Camb); 2014 Mar; 6(3):312-23. PubMed ID: 24445374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DRAM1 plays a tumor suppressor role in NSCLC cells by promoting lysosomal degradation of EGFR.
    Geng J; Zhang R; Yuan X; Xu H; Zhu Z; Wang X; Wang Y; Xu G; Guo W; Wu J; Qin ZH
    Cell Death Dis; 2020 Sep; 11(9):768. PubMed ID: 32943616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTPN3 Inhibits the Growth and Metastasis of Clear Cell Renal Cell Carcinoma via Inhibition of PI3K/AKT Signaling.
    Peng XS; Yang JP; Qiang YY; Sun R; Cao Y; Zheng LS; Peng LX; Lang YH; Mei Y; Li CZ; Meng DF; Liu ZJ; Wang MD; Zhou FJ; Huang BJ; Qian CN
    Mol Cancer Res; 2020 Jun; 18(6):903-912. PubMed ID: 32169891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 7. Angio-associated migratory cell protein interacts with epidermal growth factor receptor and enhances proliferation and drug resistance in human non-small cell lung cancer cells.
    Yao S; Shi F; Wang Y; Sun X; Sun W; Zhang Y; Liu X; Liu X; Su L
    Cell Signal; 2019 Sep; 61():10-19. PubMed ID: 31075398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRS4 promotes the progression of non-small cell lung cancer and confers resistance to EGFR-TKI through the activation of PI3K/Akt and Ras-MAPK pathways.
    Hao P; Huang Y; Peng J; Yu J; Guo X; Bao F; Dian Z; An S; Xu TR
    Exp Cell Res; 2021 Jun; 403(2):112615. PubMed ID: 33894221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CMTM7 knockdown increases tumorigenicity of human non-small cell lung cancer cells and EGFR-AKT signaling by reducing Rab5 activation.
    Liu B; Su Y; Li T; Yuan W; Mo X; Li H; He Q; Ma D; Han W
    Oncotarget; 2015 Dec; 6(38):41092-107. PubMed ID: 26528697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-574-5p in gastric cancer cells promotes angiogenesis by targeting protein tyrosine phosphatase non-receptor type 3 (PTPN3).
    Zhang S; Zhang R; Xu R; Shang J; He H; Yang Q
    Gene; 2020 Apr; 733():144383. PubMed ID: 31972307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [TRAF4 promotes lung cancer development by activating tyrosine kinase of EGFR].
    Nie XM; Dong DF; Lin JF; Wu BY; Cai G
    Zhonghua Zhong Liu Za Zhi; 2024 Oct; 46(10):968-978. PubMed ID: 39414598
    [No Abstract]   [Full Text] [Related]  

  • 12. Suppression of hepatitis B viral gene expression by protein-tyrosine phosphatase PTPN3.
    Hsu EC; Lin YC; Hung CS; Huang CJ; Lee MY; Yang SC; Ting LP
    J Biomed Sci; 2007 Nov; 14(6):731-44. PubMed ID: 17588219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells.
    Morello V; Cabodi S; Sigismund S; Camacho-Leal MP; Repetto D; Volante M; Papotti M; Turco E; Defilippi P
    Oncogene; 2011 Sep; 30(39):4087-96. PubMed ID: 21478906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients.
    Gao Q; Zhao YJ; Wang XY; Guo WJ; Gao S; Wei L; Shi JY; Shi GM; Wang ZC; Zhang YN; Shi YH; Ding J; Ding ZB; Ke AW; Dai Z; Wu FZ; Wang H; Qiu ZP; Chen ZA; Zhang ZF; Qiu SJ; Zhou J; He XH; Fan J
    Gastroenterology; 2014 May; 146(5):1397-407. PubMed ID: 24503127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eps15 is recruited to the plasma membrane upon epidermal growth factor receptor activation and localizes to components of the endocytic pathway during receptor internalization.
    Torrisi MR; Lotti LV; Belleudi F; Gradini R; Salcini AE; Confalonieri S; Pelicci PG; Di Fiore PP
    Mol Biol Cell; 1999 Feb; 10(2):417-34. PubMed ID: 9950686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLCγ1‑dependent invasion and migration of cells expressing NSCLC‑associated EGFR mutants.
    Mittal S; Kamath A; Joseph AM; Rajala MS
    Int J Oncol; 2020 Oct; 57(4):989-1000. PubMed ID: 32945365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.
    Baumgartner U; Berger F; Hashemi Gheinani A; Burgener SS; Monastyrskaya K; Vassella E
    Mol Cancer; 2018 Feb; 17(1):44. PubMed ID: 29455644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA DUXAP9-206 directly binds with Cbl-b to augment EGFR signaling and promotes non-small cell lung cancer progression.
    Zhu T; An S; Choy MT; Zhou J; Wu S; Liu S; Liu B; Yao Z; Zhu X; Wu J; He Z
    J Cell Mol Med; 2019 Mar; 23(3):1852-1864. PubMed ID: 30515972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of EGFR trafficking and cell signaling by Sprouty2 and MIG6 in lung cancer cells.
    Walsh AM; Lazzara MJ
    J Cell Sci; 2013 Oct; 126(Pt 19):4339-48. PubMed ID: 23868981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of panitumumab alone or with chemotherapy in non-small cell lung carcinoma cell lines expressing mutant epidermal growth factor receptor.
    Freeman DJ; Bush T; Ogbagabriel S; Belmontes B; Juan T; Plewa C; Van G; Johnson C; Radinsky R
    Mol Cancer Ther; 2009 Jun; 8(6):1536-46. PubMed ID: 19509246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.